Header Logo

Connection

Wajeeha Razaq to BRCA1 Protein

This is a "connection" page, showing publications Wajeeha Razaq has written about BRCA1 Protein.
Connection Strength

0.051
  1. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early?breast cancer. Ann Oncol. 2022 Dec; 33(12):1250-1268.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.